Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BL, ? 4.1mm RC, SLActive 10mm, TiZr, NTP: medical device reports filed with FDA

12,947 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

12,947
device reports naming the brand
0.1% of all MAUDE reports · about 1,873 a year
1,539
reports, 12 months to August 2026
1,825 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 12,947 reports that name the brand "BL, ? 4.1mm RC, SLActive 10mm, TiZr, NTP" (endosseous dental implant), received between August 2019 and August 2026; the manufacturer given most often on reports is Institut Straumann. Spellings of one product vary from report to report.

1,539 reports arrived in the 12 months to August 2026, down 16% from 1,825 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (66.8%), loss of osseointegration (25.7%) and fracture (1.3%). The patient problems coded most often are fibrosis, pain and tissue damage. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

0184367Sep 2021: 143Oct 2021: 165Nov 2021: 135Dec 2021: 1132022Jan 2022: 167Feb 2022: 143Mar 2022: 135Apr 2022: 145May 2022: 158Jun 2022: 130Jul 2022: 130Aug 2022: 153Sep 2022: 123Oct 2022: 170Nov 2022: 203Dec 2022: 1822023Jan 2023: 137Feb 2023: 166Mar 2023: 140Apr 2023: 187May 2023: 199Jun 2023: 173Jul 2023: 192Aug 2023: 185Sep 2023: 138Oct 2023: 156Nov 2023: 162Dec 2023: 1912024Jan 2024: 169Feb 2024: 139Mar 2024: 155Apr 2024: 168May 2024: 186Jun 2024: 116Jul 2024: 175Aug 2024: 166Sep 2024: 169Oct 2024: 140Nov 2024: 174Dec 2024: 1492025Jan 2025: 124Feb 2025: 150Mar 2025: 183Apr 2025: 86May 2025: 0Jun 2025: 367Jul 2025: 142Aug 2025: 141Sep 2025: 133Oct 2025: 173Nov 2025: 105Dec 2025: 1422026Jan 2026: 106Feb 2026: 90Mar 2026: 137Apr 2026: 122May 2026: 93Jun 2026: 147Jul 2026: 141Aug 2026: 150

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

01,0132,0262019: 1,29620192020: 1,49520202021: 1,65320212022: 1,83920222023: 2,02620232024: 1,90620242025: 1,74620252026: 9862026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%12,947
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report84.2%10,901
Voluntary report0%0
User facility report0%0
Distributor report15.8%2,046
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate8,64766.8%62.8%
Loss of osseointegration3,32325.7%22.4%
Fracturea broken bone1701.3%1.6%
Difficult to insertthe device was hard to insert1231%0.4%
Separation failure150.1%0.1%
Unintended movement130.1%0%
Unstable120.1%0%
Difficult to removethe device was hard to remove70.1%0%
Therapeutic or diagnostic output failure50%0%
Insufficient device problem information20%0.2%
Activation, positioning or separation problem10%0%
Defective devicethe device was defective10%0%
Output problem10%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis3,75429%
Painpain, site not specified2,48419.2%
Tissue damage1,75013.5%
Inflammationinflammation1,2839.9%
Swelling/ edema8226.3%
Hemorrhage/blood loss/bleeding7585.9%
Fistula5254.1%
Abscessa collection of pus4193.2%
Hyperresponsive to stimuli2652%
Swellingswelling1511.2%
Hypersensitivity/allergic reaction1200.9%
Failure of implant1000.8%
Inadequate osseointegration630.5%
Sinus perforation540.4%
Numbnessnumbness500.4%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBL, ? 4.1mm RC, SLActive 10mm, TiZr, NTPProduct code DZEAll MAUDE reports
Reports12,9473,924,24126,136,888
Share of that pool—0.3%0.1%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer84.2%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BL, ? 4.1mm RC, SLActive 10mm, TiZr, NTP reports

How many FDA reports name BL, ? 4.1mm RC, SLActive 10mm, TiZr, NTP?

12,947 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 1,539 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (66.8%), loss of osseointegration (25.7%), fracture (1.3%), difficult to insert (1%) and separation failure (0.1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (84.2%) and distributor reports (15.8%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BL, ? 4.1mm RC, SLActive 10mm, TiZr, NTP was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.